AAH arana therapeutics limited

After the merger, AAH was expected to have $167mil in cash and...

  1. 654 Posts.
    After the merger, AAH was expected to have $167mil in cash and 235mil shares on issue, so that's cash value of $0.71

    Add to that the $17.7mil recently received, less running costs since the merger, add the $100+mil expected in from the current patents until they expire in 2010... gives a cash value (before discounting and other running costs) of around $1.20.

    So it's pretty much trading below cash value right now!
 
watchlist Created with Sketch. Add AAH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.